Physician profile
James Nace
NPI 1528219334
$102,292.62
in general payments reported to CMS, 2019-2025
34 companies · $12K in 2025
The $12K reported for 2025 was more than what 78% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,967 · 2020: $5,763 · 2021: $14K · 2022: $20K · 2023: $11K · 2024: $37K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $31K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $5,830 · Food and Beverage: $5,390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $31,482.71 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $17,465.96 |
| Travel and Lodging | $5,830.18 |
| Food and Beverage | $5,390.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microport Orthopedics INC | $93,441.32 | 2019-2025 | Mpo Medial Pivot Knee, Mpo Hip System |
| Stryker Corporation | $4,004.44 | 2019-2025 | Mako, Insignia, Accolade |
| Supreme Orthopedic Systems, LLC | $1,200.00 | 2021 | |
| Depuy Synthes Sales INC. | $936.74 | 2021-2025 | Velys, Monovisc, Orthovisc |
| Ethicon US, LLC | $455.62 | 2019-2025 | Ethicon, Vistaseal, Stratafix |
| Baxter Healthcare | $395.75 | 2020-2023 | Floseal |
| Zimmer Biomet Holdings, INC. | $238.61 | 2019-2025 | Avitus Bone Harvester, Comprehensive Shoulder System, Arcos |
| Smith+Nephew, INC. | $204.99 | 2021-2025 | Trigen Intertan, Evos, Panta 2 |
| Polymedics Innovations INC. | $162.18 | 2023 | |
| Globus Medical, INC. | $157.63 | 2024-2025 | Creo S2ai, Creo One Robotic Screw, Coalition Agx / Agx Rp |
| Electronic Waveform Lab, INC. | $140.36 | 2023 | |
| Davol INC. | $132.67 | 2022 | |
| Medacta USA, INC. | $132.48 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $101.92 | 2023 | Arista Ah Flexitip |
| Bioventus LLC | $96.24 | 2019-2025 | Exogen Ultrasound Bone Healing System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $84.43 | 2019-2020 | |
| Kci USA, INC. | $41.73 | 2022 | |
| Exactech, INC. | $39.87 | 2023 | |
| Janssen Pharmaceuticals, INC | $38.72 | 2022-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $34.30 | 2020-2023 | |
| Biocomposites INC | $29.23 | 2025 | Stimulan |
| Linvatec Corporation | $24.85 | 2025 | Biobrace 23mm |
| Vericel Corporation | $21.31 | 2022 | |
| Sanara Medtech INC. | $19.47 | 2024 | Celleraterx |
| Tactile Systems Technology INC | $18.71 | 2020 | |
| Ucb, INC. | $18.27 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $17.79 | 2019 | |
| Fidia Pharma USA INC. | $17.44 | 2024 | Triluron, Hymovis, Hyalgan |
| Pfizer INC. | $17.15 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $16.49 | 2025 | |
| Lifenet Health | $15.70 | 2025 | Theragenesis Wound Matrix |
| Motive Health, INC. | $13.86 | 2019 | |
| Aroa Biosurgery Incorporated | $13.20 | 2020 | |
| Orthofix Medical, INC. | $9.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Nace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.